AR049418A1 - Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. - Google Patents
Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes.Info
- Publication number
- AR049418A1 AR049418A1 ARP050100628A ARP050100628A AR049418A1 AR 049418 A1 AR049418 A1 AR 049418A1 AR P050100628 A ARP050100628 A AR P050100628A AR P050100628 A ARP050100628 A AR P050100628A AR 049418 A1 AR049418 A1 AR 049418A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- optionally substituted
- halo
- alkoxy
- alkylthio
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Los compuestos pertenecen a la categoría de heteroarilaminopirazoles utilizados para el tratamiento de la diabetes. Composiciones farmacéuticas que los contienen. Reivindicacion 1: Un derivado de heteroarilaminopirazol de formula (1) donde el resto de formula (2) es un radical anular heterocíclico aromático sustituido seleccionado de los restos de formulas (3); R es H, o alquilo C1-6; R1 es H, alquilo C1-6 sustituido opcionalmente con fenilo, estando dicho fenilo sustituido opcionalmente con halo, o [trialquil C1-4]sililo, alquenilo C3-6, alquinilo C3-6, cicloalquilo C3-6 sustituido opcionalmente con hasta dos sustituyentes seleccionados del grupo formado por alquilo C1-3, CF3 y halo, haloalquilo C1-3, o fenil sustituido opcionalmente con hasta dos sustituyentes seleccionados el grupo constituido por halo, alquilo C1-6, alcoxi C1-6, alquiltio C1-6, haloalquilo C1-3, haloalcoxi C1-3 y ciano; R2 es H, halo, alquilo C1-6, piridilo sustituido opcionalmente con hasta dos sustituyentes seleccionados del grupo constituido por alcoxi C1-6, alquiltio C1-6, halo y alquilo C1-6, fenilo sustituido opcionalmente con hasta dos sustituyentes seleccionados del grupo constituido por alquilo C1-6, alcoxi C1-6, alquiltio C1-6, ciano y halo, pirimidilo, tienilo sustituido opcionalmente con hasta dos sustituyentes seleccionados del grupo constituido por alquilo C1-6, alcoxi C1-6, alquiltio C1- 6, ciano y halo, benzotienilo, sustituido opcionalmente con hasta dos sustituyentes seleccionados del grupo constituido por alquilo C1-6, alcoxi C1-6, alquiltio C1-6, ciano y halo, o furilo sustituido opcionalmente con hasta dos sustituyentes seleccionados del grupo constituido por alquilo C1-6, alcoxi C1-6, alquiltio C1-6, ciano y halo; R3 es alquilo C1-6, cicloalquilo C3-6, haloalquilo C2-3 o fenilo opcionalmente sustituido con más de cuatro sustituyentes seleccionados del grupo constituido por alquilo C1-6 opcionalmente sustituido con un alcoxi C1-4, halo, haloalquilo C1-3, alcoxi C1-6, haloalcoxi C1-3, alquiltio C1-6, y ciano; R4 es alquilo C1-6 opcionalmente sustituido con un alcoxi C1-4, alcoxi C1-6, alquiltio C1-6, haloalquilo C1-3, haloalcoxi C1-3, o halo; n = 0, 1, 2, o 3; X es CO2R7, CONR5R6, o SO2NH2; R5 es H, alquilo C1-6, fenilo opcionalmente sustituido con halo o bencilo opcionalmente sustituido en el anillo fenilo con halo; R6 es H o alquilo C1-6; o R5 y R6, tomados junto con el átomo de N al cual están unidos, pueden formar un anillo de piperidina, morfolina, tiomorfolina o piperazina, dicha piperazina opcionalmente sustituida en el N con alquilo C1-3; R7 es H, alquilo C1-6, bencilo opcionalmente sustituido con hasta dos sustituyentes seleccionados del grupo constituido por halo, alquilo C1-6, alcoxi C1-3, haloalquilo C1-3, haloalcoxi C1-3 y alquiltio C1-6; fenilo opcionalmente sustituido con hasta dos sustituyentes seleccionados de alquilo C1-6, halo, alcoxi C1-6, haloalquilo C1-3, haloalcoxi C1-3 y alquiltio C1-6; y sales aceptables para uso farmacéutico del mismo con la condicion de que el compuesto de formula (1) no sea uno de los compuestos de formulas (4).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54833104P | 2004-02-27 | 2004-02-27 | |
| US57290604P | 2004-05-20 | 2004-05-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049418A1 true AR049418A1 (es) | 2006-08-02 |
Family
ID=34976070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100628A AR049418A1 (es) | 2004-02-27 | 2005-02-21 | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7517878B2 (es) |
| EP (1) | EP1720863A4 (es) |
| JP (1) | JP2007525513A (es) |
| KR (1) | KR20060124727A (es) |
| AR (1) | AR049418A1 (es) |
| AU (1) | AU2005220723A1 (es) |
| BR (1) | BRPI0508051A (es) |
| CA (1) | CA2557527A1 (es) |
| EC (1) | ECSP066883A (es) |
| IL (1) | IL177232A0 (es) |
| MA (1) | MA28479B1 (es) |
| NO (1) | NO20064325L (es) |
| PE (1) | PE20051159A1 (es) |
| RU (1) | RU2006134004A (es) |
| TW (1) | TW200538130A (es) |
| UY (1) | UY28774A1 (es) |
| WO (1) | WO2005086656A2 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006055831A2 (en) | 2004-11-17 | 2006-05-26 | Miikana Therapeutics, Inc. | Kinase inhibitors |
| WO2006065590A2 (en) * | 2004-12-16 | 2006-06-22 | Xtl Biopharmaceuticals Inc. | Pyridine and pyrimidine antiviral compositions |
| US7759339B2 (en) | 2005-03-31 | 2010-07-20 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
| CA2622352C (en) * | 2005-09-30 | 2014-05-27 | Miikana Therapeutics, Inc. | Substituted pyrazole compounds |
| UA103746C2 (en) * | 2006-03-24 | 2013-11-25 | Эррей Биофарма Инк. | 2-aminopyridine analogs as glucokinase activators |
| SA08280783B1 (ar) * | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| CA2681695A1 (en) * | 2007-03-23 | 2008-10-02 | Array Biopharma Inc. | 2-aminopyridine analogs as glucokinase activators |
| JP2010529193A (ja) * | 2007-06-11 | 2010-08-26 | ミイカナ セラピューティクス インコーポレイテッド | 置換ピラゾール化合物 |
| MY180558A (en) | 2007-09-21 | 2020-12-02 | Array Biopharma Inc | Pyridin-2-yl-amino-1,2,4- theiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| US9315449B2 (en) | 2008-05-15 | 2016-04-19 | Duke University | Substituted pyrazoles as heat shock transcription factor activators |
| EP2135865A1 (de) | 2008-06-17 | 2009-12-23 | Bayer CropScience AG | Substituierte 1-(Diazinyl) pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| DE102008039082A1 (de) | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Azabicyclisch-substituierte 5-Aminopyrazole und ihre Verwendung |
| DE102008039083A1 (de) * | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Aminopyrazole und ihre Verwendung |
| EP2194052A1 (de) | 2008-12-06 | 2010-06-09 | Bayer CropScience AG | Substituierte 1-(Thiazolyl)- und 1-(Isothiazolyl)pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| ES2712875T3 (es) * | 2009-10-06 | 2019-05-16 | Millennium Pharm Inc | Compuestos heterocíclicos útiles como inhibidores de PDK1 |
| WO2011073098A1 (de) | 2009-12-15 | 2011-06-23 | Bayer Cropscience Ag | 1-(heteroaryl)-pyrazol-4-yl-essigsäuren, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren |
| US20170291890A1 (en) * | 2014-09-17 | 2017-10-12 | Epizyme, Inc. | Heterocycle substituted amino-pyridine compounds and methods of use thereof |
| WO2016092559A1 (en) * | 2014-12-12 | 2016-06-16 | Oat & Iil India Laboratories Private Limited | Substituted pyrazole derivatives having activity as fungicides |
| WO2017087905A1 (en) | 2015-11-20 | 2017-05-26 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| US11028080B2 (en) | 2016-03-11 | 2021-06-08 | Denali Therapeutics Inc. | Substituted pyrimidines as LRKK2 inhibitors |
| KR101725292B1 (ko) | 2016-03-30 | 2017-04-10 | 한국과학기술연구원 | 항암 활성을 갖는 신규 피리미딘-4-카르복시산 유도체 |
| PT3472153T (pt) | 2016-06-16 | 2021-12-31 | Denali Therapeutics Inc | Pirimidin-2-ilamino-1h-pirazóis como inibidores de lrrk2 para uso no tratamento de distúrbios neurodegenerativos |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4405207A1 (de) * | 1994-02-18 | 1995-08-24 | Bayer Ag | N-Pyrazolylaniline und N-Pyrazolylaminopyridine |
| US20020103185A1 (en) * | 2000-08-31 | 2002-08-01 | Sanner Mark A. | Pyrazole derivatives |
| US6660731B2 (en) * | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7319102B1 (en) * | 2003-12-09 | 2008-01-15 | The Procter & Gamble Company | Pyrrolo[2,3-d]pyrimidine cytokine inhibitors |
-
2005
- 2005-02-21 AR ARP050100628A patent/AR049418A1/es unknown
- 2005-02-24 BR BRPI0508051-7A patent/BRPI0508051A/pt not_active IP Right Cessation
- 2005-02-24 KR KR1020067017159A patent/KR20060124727A/ko not_active Application Discontinuation
- 2005-02-24 JP JP2007500954A patent/JP2007525513A/ja active Pending
- 2005-02-24 US US11/064,700 patent/US7517878B2/en not_active Expired - Fee Related
- 2005-02-24 CA CA002557527A patent/CA2557527A1/en not_active Abandoned
- 2005-02-24 RU RU2006134004/04A patent/RU2006134004A/ru not_active Application Discontinuation
- 2005-02-24 EP EP05723606A patent/EP1720863A4/en not_active Withdrawn
- 2005-02-24 WO PCT/US2005/005794 patent/WO2005086656A2/en active Application Filing
- 2005-02-24 AU AU2005220723A patent/AU2005220723A1/en not_active Abandoned
- 2005-02-25 TW TW094105697A patent/TW200538130A/zh unknown
- 2005-02-25 UY UY28774A patent/UY28774A1/es not_active Application Discontinuation
- 2005-02-25 PE PE2005000226A patent/PE20051159A1/es not_active Application Discontinuation
-
2006
- 2006-08-02 IL IL177232A patent/IL177232A0/en unknown
- 2006-09-22 MA MA29334A patent/MA28479B1/fr unknown
- 2006-09-25 NO NO20064325A patent/NO20064325L/no not_active Application Discontinuation
- 2006-09-26 EC EC2006006883A patent/ECSP066883A/es unknown
-
2009
- 2009-04-13 US US12/422,804 patent/US20090209451A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0508051A (pt) | 2007-07-17 |
| PE20051159A1 (es) | 2006-02-22 |
| JP2007525513A (ja) | 2007-09-06 |
| RU2006134004A (ru) | 2008-04-10 |
| KR20060124727A (ko) | 2006-12-05 |
| WO2005086656A3 (en) | 2005-12-29 |
| NO20064325L (no) | 2006-11-22 |
| US20090209451A1 (en) | 2009-08-20 |
| AU2005220723A1 (en) | 2005-09-22 |
| EP1720863A4 (en) | 2009-04-22 |
| IL177232A0 (en) | 2006-12-10 |
| US20050192294A1 (en) | 2005-09-01 |
| UY28774A1 (es) | 2005-08-31 |
| MA28479B1 (fr) | 2007-03-01 |
| CA2557527A1 (en) | 2005-09-22 |
| EP1720863A2 (en) | 2006-11-15 |
| TW200538130A (en) | 2005-12-01 |
| US7517878B2 (en) | 2009-04-14 |
| WO2005086656A2 (en) | 2005-09-22 |
| ECSP066883A (es) | 2006-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049418A1 (es) | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. | |
| ATE537169T1 (de) | Piperidin- und piperazinderivate als p2x3- antagonisten | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CO5690643A2 (es) | Derivados de triaza-espiropiperidina para usarlos como inhibidores de glyt-1 en el tratamiento de desordenes neurologicos y neuropsiquiatricos | |
| AR054024A1 (es) | Derivados de piridina -3- carboxamida como agonistas inversos de cb1 | |
| AR055071A1 (es) | Derivados de pirrolo (3,2 - b) pirimidina. composiciones farmaceuticas. | |
| DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
| AR049116A1 (es) | Derivados de piperazina y usos para controlar pestes. | |
| DOP2010000194A (es) | Derivados de oxadiazol activos sobre fosfato de esfingosina-1 | |
| CO5640098A2 (es) | Acidos biariloximetilaren-carboxilicos | |
| ECSP088150A (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
| AR082888A1 (es) | Compuestos de piridina para la inhibicion de nampt | |
| AR047056A1 (es) | Derivados de pirimidinas condensadas. composiciones farmacéuticas | |
| AR053405A1 (es) | Derivados de urea sustituidas, composiciones farmaceuticas y metodos para el tratamiento de cardiopatias | |
| EA200870362A1 (ru) | Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида | |
| AR042067A1 (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes | |
| TW200744994A (en) | Insecticidal 3-acylaminobenzanilides | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| AR072166A1 (es) | Derivado de piperidina y su uso como inhibidor de renina superior | |
| PE20080068A1 (es) | Compuestos derivados de pirimidina como inhibidores de la quinasa aurora | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| EA201000101A1 (ru) | Производные пиримидина 934 | |
| AR063151A1 (es) | Inhibidores de metaloproteasas de matriz | |
| EA200700758A1 (ru) | Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ | |
| RS52900B (en) | Benzoylpyrazole Compound, Process for Production and Production of Herbicides Containing Them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |